Optimizing radiotherapy for Locally advanced Non-Small Cell Lung Cancer patients

Keyphrases

• Non-small Cell Lung Cancer Patients 100%
• Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) 100%
• Treatment Outcome 60%
• Concurrent Chemoradiotherapy 60%
• Cone-beam CT 40%
• Personalized Treatment 20%
• Clinical Practice 20%
• Patient Selection 20%
• Treatment Choice 20%
• Primary Tumor 20%
• Dysphagia 20%
• Overall Survival 20%
• Tumor Volume 20%
• Curative Intent 20%
• Decision Support System 20%
• Adaptive Radiotherapy 20%
• Normal Tissue Complication Probability Models 20%
• Curative Resection 20%
• Imaging Data 20%
• Oligometastatic Disease 20%
• Reduced Toxicity 20%
• Mediastinal Lymph Nodes 20%
• Dose Prescription 20%
• Esophagus Toxicity 20%
• Adjuvant Immunotherapy 20%
• Practical Decision 20%

Medicine and Dentistry

• Non Small Cell Lung Cancer 100%
• Neoplasm 20%
• Lung Cancer 20%
• Overall Survival 20%
• Esophagus 20%
• Plummer-Vinson Syndrome 20%
• Immunotherapy 20%
• Patient Selection 20%
• Primary Tumor 20%
• Mediastinal Lymph Node 20%
• Image-Guided Radiation Therapy 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Small Cell Lung Cancer 100%
• Immunotherapy 20%
• Neoplasm 20%
• Overall Survival 20%
• Lung Cancer 20%
• Dysphagia 20%
• Primary Tumor 20%